We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Dr Reddys Laboratories Ltd | NYSE:RDY | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.43 | 0.58% | 75.21 | 75.43 | 74.705 | 74.89 | 224,293 | 01:00:00 |
From May 2022 to May 2024
By Denny Jacob
International stocks trading in New York closed higher on Friday.
The S&P/BNY Mellon index of American depositary receipts rose 1% to 154.86. The Asian index climbed 1.7% to 185.63, while the emerging-markets index also gained 1.7%, to 312.19. The European index rose 0.6% to 146.88. The Latin American index edged up 0.3% to 194.89.
ABB Ltd. was among those whose ADRs traded actively.
The Swiss technology company gained 1.5% after it said it would sell its power-conversion division to Taiwan's AcBel Polytech Inc. for $505 million.
Dr. Reddy's Laboratories Ltd. ticked up 0.3% after the pharmaceutical company said it successfully completed the full set of clinical studies of its proposed rituximab biosimilar candidate, DRL_RI, for filing in markets such as the U.S., Europe and other regions.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
January 20, 2023 17:41 ET (22:41 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Dr Reddys Laboratories Chart |
1 Month Dr Reddys Laboratories Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
